ArticleHaematologica2021

Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status.

David Baker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.